This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: SOGUG-AUREA Study - Split-Dose Cisplatin and Atezolizumab in Cisplatin-Ineligible Urothelial Carcinoma

57 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login